Content of certain cytokines and chemokines in blood ofpatients with chronic hepatitis B in the early stages of liver fibrosis

Hepatitis B is an infectious viral disease in which damage or destruction of liver tissue occurs, and which can turn into a chronic form. In chronic hepatitis B (CHB), hepatocytes are replaced by connective tissue as they die, resulting in fibrosis, and then cirrhosis of the liver. Early diagnosis o...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	O. K. Batsunov, N. A. Arsentieva, N. E. Lyubimova, E. V. Esaulenko, A. V. Semenov, Areg A. Totolyan
Formato:	article
Lenguaje:	RU
Publicado:	SPb RAACI 2020
Materias:	cytokines chemokines chronic hepatitis b liver fibrosis Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/d43b7330c5304e90895bc01ebc881c6e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:d43b7330c5304e90895bc01ebc881c6e
record_format	dspace
spelling	oai:doaj.org-article:d43b7330c5304e90895bc01ebc881c6e2021-11-18T08:03:49ZContent of certain cytokines and chemokines in blood ofpatients with chronic hepatitis B in the early stages of liver fibrosis1563-06252313-741X10.15789/1563-0625-COC-1964https://doaj.org/article/d43b7330c5304e90895bc01ebc881c6e2020-04-01T00:00:00Zhttps://www.mimmun.ru/mimmun/article/view/1964https://doaj.org/toc/1563-0625https://doaj.org/toc/2313-741XHepatitis B is an infectious viral disease in which damage or destruction of liver tissue occurs, and which can turn into a chronic form. In chronic hepatitis B (CHB), hepatocytes are replaced by connective tissue as they die, resulting in fibrosis, and then cirrhosis of the liver. Early diagnosis of liver fibrosis is an urgent task in the development of CHB. Already at this stage of the disease, the immune system is activated, which plays a leading role in liver damage in CHB. The main regulators of immune processes are cytokines, which mediate intercellular interactions. A separate group of cytokines are chemokines — proteins of cell migration. In CHB, they are responsible for infiltration of liver tissue by activated white blood cells. Cytokines and chemokines are active participants in fibrogenesis, so they can serve as biomarkers for the development of liver fibrosis, including in the early stages. The purpose of this study was to analyze the content of certain cytokines/chemokines in the peripheral blood of patients with CHB in order to search for potential biomarkers of the initial stages of liver fibrosis. The study included 30 patients with a confirmed diagnosis of CHB with stages of liver fibrosis F0-F1 on the Metavir scale, 36 patients with a diagnosis of chronic hepatitis C (F0-F1) and 37 conditionally healthy individuals as a control group. Concentrations of the following cytokines/chemokines were determined: IFNγ, TNFα, CCL2/MCP-1, CCL8/MCP-2, CCL20/MIP-3α, CXCL9/MIG, CXCL10/IP-10, CXCL11/I-TAC by multiplex analysis using xMAP technology (Luminex, USA). As a result of the study, it was found that in patients with CHB, the plasma content of cytokine TNFα and chemokines CCL2/MCP-1, CXCL9/MIG and CXCL10/IP-10 was increased, and the chemokine CCL8/MCP-2 was reduced, which indicates the possibility of using these cytokines/chemokines as biomarkers of liver damage in CHB. In the examined group of patients with CHB, there was no dependence of the concentrations of cytokines and chemokines in the blood plasma on the viral load, which may be explained by its low level. For plasma cytokines in patients with CHB, correlations were found between TNFα and CCL2/MCP-1 and CCL8/MCP-2 chemokines , which was not observed in the control group. At the same time, in the control group, a correlation was found between the content of TNFα and the chemokine CXCL9/MIG, which was not detected in the group of patients. For both groups, a correlation was found between the content of CXCL9/MIG and CXCL10/IP-10 chemokines. Based on the study data, an algorithm has been developed that allows us to establish chronic hepatitis B or chronic hepatitis C as the cause of the initial form of fibrosis F0-F1 in terms of the content of cytokines IFNγ, CCL2/MCP-1 and CCL8/MCP-2 in blood plasma with a diagnostic efficiency of 89.4%.O. K. BatsunovN. A. ArsentievaN. E. LyubimovaE. V. EsaulenkoA. V. SemenovAreg A. TotolyanSPb RAACIarticlecytokineschemokineschronic hepatitis bliver fibrosisImmunologic diseases. AllergyRC581-607RUMedicinskaâ Immunologiâ, Vol 22, Iss 2, Pp 291-300 (2020)
institution	DOAJ
collection	DOAJ
language	RU
topic	cytokines chemokines chronic hepatitis b liver fibrosis Immunologic diseases. Allergy RC581-607
spellingShingle	cytokines chemokines chronic hepatitis b liver fibrosis Immunologic diseases. Allergy RC581-607 O. K. Batsunov N. A. Arsentieva N. E. Lyubimova E. V. Esaulenko A. V. Semenov Areg A. Totolyan Content of certain cytokines and chemokines in blood ofpatients with chronic hepatitis B in the early stages of liver fibrosis
description	Hepatitis B is an infectious viral disease in which damage or destruction of liver tissue occurs, and which can turn into a chronic form. In chronic hepatitis B (CHB), hepatocytes are replaced by connective tissue as they die, resulting in fibrosis, and then cirrhosis of the liver. Early diagnosis of liver fibrosis is an urgent task in the development of CHB. Already at this stage of the disease, the immune system is activated, which plays a leading role in liver damage in CHB. The main regulators of immune processes are cytokines, which mediate intercellular interactions. A separate group of cytokines are chemokines — proteins of cell migration. In CHB, they are responsible for infiltration of liver tissue by activated white blood cells. Cytokines and chemokines are active participants in fibrogenesis, so they can serve as biomarkers for the development of liver fibrosis, including in the early stages. The purpose of this study was to analyze the content of certain cytokines/chemokines in the peripheral blood of patients with CHB in order to search for potential biomarkers of the initial stages of liver fibrosis. The study included 30 patients with a confirmed diagnosis of CHB with stages of liver fibrosis F0-F1 on the Metavir scale, 36 patients with a diagnosis of chronic hepatitis C (F0-F1) and 37 conditionally healthy individuals as a control group. Concentrations of the following cytokines/chemokines were determined: IFNγ, TNFα, CCL2/MCP-1, CCL8/MCP-2, CCL20/MIP-3α, CXCL9/MIG, CXCL10/IP-10, CXCL11/I-TAC by multiplex analysis using xMAP technology (Luminex, USA). As a result of the study, it was found that in patients with CHB, the plasma content of cytokine TNFα and chemokines CCL2/MCP-1, CXCL9/MIG and CXCL10/IP-10 was increased, and the chemokine CCL8/MCP-2 was reduced, which indicates the possibility of using these cytokines/chemokines as biomarkers of liver damage in CHB. In the examined group of patients with CHB, there was no dependence of the concentrations of cytokines and chemokines in the blood plasma on the viral load, which may be explained by its low level. For plasma cytokines in patients with CHB, correlations were found between TNFα and CCL2/MCP-1 and CCL8/MCP-2 chemokines , which was not observed in the control group. At the same time, in the control group, a correlation was found between the content of TNFα and the chemokine CXCL9/MIG, which was not detected in the group of patients. For both groups, a correlation was found between the content of CXCL9/MIG and CXCL10/IP-10 chemokines. Based on the study data, an algorithm has been developed that allows us to establish chronic hepatitis B or chronic hepatitis C as the cause of the initial form of fibrosis F0-F1 in terms of the content of cytokines IFNγ, CCL2/MCP-1 and CCL8/MCP-2 in blood plasma with a diagnostic efficiency of 89.4%.
format	article
author	O. K. Batsunov N. A. Arsentieva N. E. Lyubimova E. V. Esaulenko A. V. Semenov Areg A. Totolyan
author_facet	O. K. Batsunov N. A. Arsentieva N. E. Lyubimova E. V. Esaulenko A. V. Semenov Areg A. Totolyan
author_sort	O. K. Batsunov
title	Content of certain cytokines and chemokines in blood ofpatients with chronic hepatitis B in the early stages of liver fibrosis
title_short	Content of certain cytokines and chemokines in blood ofpatients with chronic hepatitis B in the early stages of liver fibrosis
title_full	Content of certain cytokines and chemokines in blood ofpatients with chronic hepatitis B in the early stages of liver fibrosis
title_fullStr	Content of certain cytokines and chemokines in blood ofpatients with chronic hepatitis B in the early stages of liver fibrosis
title_full_unstemmed	Content of certain cytokines and chemokines in blood ofpatients with chronic hepatitis B in the early stages of liver fibrosis
title_sort	content of certain cytokines and chemokines in blood ofpatients with chronic hepatitis b in the early stages of liver fibrosis
publisher	SPb RAACI
publishDate	2020
url	https://doaj.org/article/d43b7330c5304e90895bc01ebc881c6e
work_keys_str_mv	AT okbatsunov contentofcertaincytokinesandchemokinesinbloodofpatientswithchronichepatitisbintheearlystagesofliverfibrosis AT naarsentieva contentofcertaincytokinesandchemokinesinbloodofpatientswithchronichepatitisbintheearlystagesofliverfibrosis AT nelyubimova contentofcertaincytokinesandchemokinesinbloodofpatientswithchronichepatitisbintheearlystagesofliverfibrosis AT evesaulenko contentofcertaincytokinesandchemokinesinbloodofpatientswithchronichepatitisbintheearlystagesofliverfibrosis AT avsemenov contentofcertaincytokinesandchemokinesinbloodofpatientswithchronichepatitisbintheearlystagesofliverfibrosis AT aregatotolyan contentofcertaincytokinesandchemokinesinbloodofpatientswithchronichepatitisbintheearlystagesofliverfibrosis
_version_	1718422318534885376

Content of certain cytokines and chemokines in blood ofpatients with chronic hepatitis B in the early stages of liver fibrosis

Ejemplares similares